Avermectin

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Avermectin is a family of anti-parasitic drugs whose analogues include ivermectin, selamectin, doramectin and abamectin.

Avermectin therapy for rodent fur mite infestation

A commonly used therapy in recent times has been based on oral or parenteral administration of avermectins, which are macrocyclic lactones produced by fermentation of the soil micro-organism Streptomyces avermitilis. They show activity against a broad range of nematodes and arthropod parasites of domestic animals at dose rates of 300 microgram/kg or less. Unlike the macrolide or polyene antibiotics, they lack significant antibacterial or antifungal activity (Hotson, 1982).

Avermectin therapy is not without its drawbacks. Resistance to avermectins has been reported, which suggests use in moderation (Clark, 1995). Research on ivermectin, piperazine, and dichlorvos in combinations also shows potential for toxicity (Toth, 2000). Avermectin has been reported to block LPS-induced secretion of tumor necrosis factor, nitric oxide, prostaglandin E2, and increase of intracellular concentration of Ca2+ (Victorov, 2003). A proven ectoparasite mitigation method that stresses lab animals less than avermectin oral administration is definitely desirable. Permethrin based treatments such as MiteArrest may be a viable alternative.

References

  • Hotson IK, 1982, The avermectins: A new family of antiparasitic agents, J S Afr Vet Assoc., Jun;53(2):87-90.
  • Clark JM, 1995, with Scott JG, Campos F, Bloomquist JR, Resistance to avermectins: extent, mechanisms, and management implications, Annu Rev Entomol, 40:1-30.
  • Toth LA, 2000, with Oberbeck C, Straign CM, Frazier S, Rehg JE, Toxicity evaluation of prophylactic treatments for mites and pinworms in mice, Contemp Top Lab Anim Sci., Mar;39(2):18-21.
  • Viktorov AV, 2003, with Yurkiv VA, Effect of ivermectin on function of liver macrophages, Bull Exp Biol Med., Dec;136(6):569-71.de:Avermectine

sv:Avermectin uk:Авермектин


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

related articles
viewed previously [ + ]